Implant failure associated with oral bisphosphonate-related osteonecrosis of the jaw

키워드

참고문헌 (20)

1. Wang HL, "Effect of long-term oral bisphosphonates on implant wound healing: literature review and a case report", J Periodontol, 78, pp.584~594 (2007)
2. Ruggiero SL, "Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases", J Oral Maxillofac Surg, 62, pp.527~534 (2004)
3. Marx RE, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
4. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate- related osteonecrosis of the jaws", J Oral Maxillofac Surg, 65, pp.369~376 (2007)
5. American Dental Association Council on Scientific Affairs, "Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations", J Am Dent Assoc, 137, pp.1144~1150 (2006)
6. Ruggiero SL, "American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw: 2009 update", J Oral Maxillofac Surg, 67, pp.2~12 (2009)
7. Badros A, "Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors", J Clin Oncol, 24, pp.945~952 (2006)
8. Bamias A, "Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors", J Clin Oncol, 23, pp.8580~8587 (2005)
9. Marx RE, "Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment", J Oral Maxillofac Surg, 65, pp.2397~2410 (2007)
10. Rosen HN, "Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy", Calcif Tissue Int, 66, pp.100~103 (2000)
11. Migliorati CA, "Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper", J Am Dent Assoc, 136, pp.1658~1668 (2005)
12. Bone HG, "Ten years’ experience with alendronate for osteoporosis in postmenopausal women", N Engl J Med, 350, pp.1189~1199 (2004)
13. Bagan JV, "Jaw osteonecrosis associated with bisphosphonates:multiple exposed areas and its relationship to teeth extractions. Study of 20 cases", Oral Oncol, 42, pp.327~329 (2006)
14. Kademani D, "Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy", Mayo Clin Proc, 81, pp.1100~1103 (2006)
15. review:bisphosphonates and osteonecrosis of the jaws, "Ann Intern Med", 2006, 753~761
16. Marx RE, "Bisphosphonate- induced exposed bone (osteonecrosis", osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment, 2005, pp.63, 1567~1575
17. Jeffcoat MK, "Safety of oral bisphosphonates: controlled studies on alveolar bone", Int J Oral Maxillofac Implants, 21, pp.349~353 (2006)
18. Madrid C, "What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review", Clin Oral Implants Res, 20(Suppl 4), pp.87~95 (2009)
19. Ripamonti CI, "Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates: the experience of the National Cancer Institute of Milan", Ann Oncol, 20, pp.137~145 (2009)
20. Dimopoulos MA, "Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid", Ann Oncol, 20, pp.117~120 (2009)

관련 논문AI추천